Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.10.2019 | Case report

Methylprednisolone/prednisone

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Coffey K, et al. Successful treatment of corticosteroid-refractory hypereosinophilia with reslizumab. Journal of Investigational Allergology and Clinical Immunology 29: 241-242, No. 3, Jan 2019. Available from: URL: http://doi.org/10.18176/jiaci.0366 - USA Coffey K, et al. Successful treatment of corticosteroid-refractory hypereosinophilia with reslizumab. Journal of Investigational Allergology and Clinical Immunology 29: 241-242, No. 3, Jan 2019. Available from: URL: http://​doi.​org/​10.​18176/​jiaci.​0366 - USA
Metadaten
Titel
Methylprednisolone/prednisone
Lack of efficacy: case report
Publikationsdatum
01.10.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-68989-5

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Erlotinib

Case report

Metformin

Case report

Cefuroxime